Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 May;16(2):422–431. doi: 10.1128/iai.16.2.422-431.1977

Protective Effect of Vaccines on Mycoplasma pulmonis-Induced Respiratory Disease of Mice

Geraldine Taylor 1, C J Howard 1, R N Gourlay 1
PMCID: PMC420967  PMID: 558962

Abstract

Mice inoculated intranasally with either a virulent or an avirulent strain of live Mycoplasma pulmonis were resistant to respiratory disease induced by a subsequent intranasal challenge with virulent organisms. Similarly, mice inoculated intravenously with the virulent strain were resistant to intranasal challenge with the same strain. In contrast, mice inoculated intravenously with avirulent M. pulmonis were not resistant to intranasal challenge with the virulent mycoplasma strain. Studies on mice inoculated intravenously with the two strains of M. pulmonis indicated that persistance of mycoplasmas in the respiratory tract may be important in inducing resistance to intranasal challenge with M. pulmonis. These observations, together with the lack of correlation between the level of serum antibodies and resistance to M. pulmonis-induced respiratory disease, suggested that local immune mechanisms were important in resistance. It is proposed that an effective vaccination schedule to protect mice against M. pulmonis-induced respiratory disease may be one that stimulates both systemic and local immune defenses. This suggestion is supported by the observation that systemic followed by local administration of inactivated M. pulmonis was more effective in inducing resistance in mice to intranasal challenge with live organisms than was systemic administration alone. In addition, mice inoculated solely by the intranasal route with inactivated mycoplasmas were resistant to M. pulmonis-induced respiratory disease. These studies indicate the importance of local defense mechanisms in the induction of resistance to M. pulmonis-induced respiratory disease in mice.

Full text

PDF
422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRADSTREET C. M., TAYLOR C. E. Technique of complementfixation test applicable to the diagnosis of virus diseases. Mon Bull Minist Health Public Health Lab Serv. 1962 May;21:96–104. [PubMed] [Google Scholar]
  2. Barden J. A., Tully J. G. Experimental arthritis in mice with Mycoplasma pulmonis. J Bacteriol. 1969 Oct;100(1):5–10. doi: 10.1128/jb.100.1.5-10.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brunner H., Greenberg H. B., James W. D., Horswood R. L., Couch R. B., Chanock R. M. Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun. 1973 Oct;8(4):612–620. doi: 10.1128/iai.8.4.612-620.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clyde W. A., Jr Immunopathology of experimental Mycoplasma pneumoniae disease. Infect Immun. 1971 Dec;4(6):757–763. doi: 10.1128/iai.4.6.757-763.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Collier A. M., Clyde W. A. Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium. Infect Immun. 1971 May;3(5):694–701. doi: 10.1128/iai.3.5.694-701.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Denny F. W., Taylor-Robinson D., Allison A. C. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol. 1972 Aug;5(3):327–336. doi: 10.1099/00222615-5-3-327. [DOI] [PubMed] [Google Scholar]
  7. Fernald G. W., Clyde W. A., Jr, Bienenstock J. Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae. J Immunol. 1972 May;108(5):1400–1408. [PubMed] [Google Scholar]
  8. Fernald G. W., Clyde W. A. Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease. Infect Immun. 1970 Jun;1(6):559–565. doi: 10.1128/iai.1.6.559-565.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gois M., Kuksa F., Franz J. Influence of intraperitoneal administration of hyperimmune pig serum, IgG and IgM on the development of infection in gnotobiotic piglets infected intranasally with Mycoplasma hyorhinis. Zentralbl Veterinarmed B. 1974 Mar;21(3):176–187. doi: 10.1111/j.1439-0450.1974.tb00490.x. [DOI] [PubMed] [Google Scholar]
  10. Goodwin R. F., Hodgson R. G., Whittlestone P., Woodhams R. L. Some experiments relating to artificial immunity in enzootic pneumonia of pigs. J Hyg (Lond) 1969 Sep;67(3):465–476. doi: 10.1017/s0022172400041887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gourlay R. N., Howard C. J., Brownlie J. Localized immunity in experimental bovine mastitis caused by Mycoplasma dispar. Infect Immun. 1975 Nov;12(5):947–950. doi: 10.1128/iai.12.5.947-950.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gourlay R. N., Leach R. H. A new mycoplasma species isolated from pneumonic lungs of calves (Mycoplasma dispar sp. nov.). J Med Microbiol. 1970 Feb;3(1):111–123. doi: 10.1099/00222615-3-1-111. [DOI] [PubMed] [Google Scholar]
  13. Howard C. J., Gourlay R. N., Brownlie J. Immunity in experimental T-mycoplasma mastitis. Infect Immun. 1974 Feb;9(2):400–403. doi: 10.1128/iai.9.2.400-403.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Lam K. M., Switzer W. P. Mycoplasmal pneumonia of swine: active and passive immunizations. Am J Vet Res. 1971 Nov;32(11):1737–1741. [PubMed] [Google Scholar]
  16. Masiga W. N., Roberts D. H., Kakoma I., Rurangirwa F. R. Passive immunity to contagious bovine pleuropneumonia. Res Vet Sci. 1975 Nov;19(3):330–332. [PubMed] [Google Scholar]
  17. Murray M. Local immunity and its role in vaccination. Vet Rec. 1973 Nov 10;93(19):500–504. doi: 10.1136/vr.93.19.500. [DOI] [PubMed] [Google Scholar]
  18. Organick A. B., Siegesmund K. A., Lutsky I. I. Pneumonia due to mycoplasma in gnotobiotic mice. II. Localization of Mycoplasma pulmonis in the lungs of infected gnotobiotic mice by electron microscopy. J Bacteriol. 1966 Oct;92(4):1164–1176. doi: 10.1128/jb.92.4.1164-1176.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pierce N. F., Gowans J. L. Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med. 1975 Dec 1;142(6):1550–1563. doi: 10.1084/jem.142.6.1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pierce N. F. Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid. Ciba Found Symp. 1976;(42):129–147. doi: 10.1002/9780470720240.ch8. [DOI] [PubMed] [Google Scholar]
  21. Taylor-Robinson D., Denny F. W., Thompson G. W., Allison A. C., Mårdh P. A. Isolation of mycoplasmas from lungs by a perfusion technique. Med Microbiol Immunol. 1972;158(1):9–15. doi: 10.1007/BF02122003. [DOI] [PubMed] [Google Scholar]
  22. Taylor G., Taylor-Robinson D. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology. 1976 May;30(5):611–618. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES